Vitamin K and Reduced Adverse Event

• Anticancer effects of vitamin K combined with transarterial chemoembolization in hepatocellular carcinoma, a randomized controlled trial.

  • 2025-04-22
  • RCT · n = 51
  • British journal of cancer 132(12)
  • • Yoshimichi Haruna
    • Takayuki Yakushijin
    • Miho Yamakawa
    • Tetsuo Nakazawa

  • PubMed: 40263401
  • DOI: 10.1038/s41416-025-03022-4

  3 Insights on

  • Reduced Adverse Event

  • High evidence
  • Clinical

  There were no significant differences in the incidence of adverse events between groups.

  Effect

  Neutral

  Effect size

  Small

  Significant

  No